In addition, AC133, a glycosylated epitope of CD133 protein initially associated with embryonic stem cells [8] and a variety of somatic stem cells, was extensively described as a putative cancer stem cell marker in blood, brain, colon, prostate, lung, breast, liver, and skin cancers [9], [10]. The gene discussed is PROM1; the disease is skin neoplasm.